UiPath (PATH) Trades 25% Below Analyst Targets After 36% Year-to-Date Slide

1 week ago 11

Thomas Richmond

Sun, April 12, 2026 astatine 9:13 AM CDT 5 min read

UiPath (PATH) reported Q4 gross of $481M (up 14% YoY) and achieved full-year GAAP profitability for the archetypal time, with non-GAAP operating margins astatine 31% and dollar-based nett retention holding astatine 107%, but cautious fiscal 2027 guidance triggered expert downgrades contempt the beat.
CEO Daniel Dines and different executives sold important shares astatine higher prices portion the banal declined 36.55% YTD, signaling absorption assurance concerns adjacent arsenic the marketplace struggles to reconcile UiPath’s profitable maturation successful agentic AI automation with slowing ARR maturation guidance.
The expert who called NVIDIA successful 2010 conscionable named his apical 10 AI stocks. Get them present FREE.

UiPath (NYSE:PATH) presently trades astatine $10.39, portion the mean expert terms people sits astatine $13.80, implying upside of astir 33% from existent levels.

UiPath sells endeavor automation bundle combining AI agents, robotic process automation, and quality workflows into a azygous platform. The institution has positioned itself astatine the halfway of the agentic AI wave, with integrations spanning Microsoft Azure AI Foundry, OpenAI, NVIDIA, Snowflake, and Google. A spread this wide typically signals a disconnect betwixt existent fundamentals and what analysts expect the concern to become.

UiPath has shed 36.55% year-to-date. The astir caller catalyst was a gut punch: the institution delivered a Q4 bushed connected gross and EPS but issued cautious fiscal 2027 guidance. Morgan Stanley, Mizuho, and Wells Fargo each lowered their terms targets successful response, sending shares down astir 6%. When a institution beats estimates and inactive gets punished, the marketplace is signaling interest astir guardant expectations.

READ: The expert who called NVIDIA successful 2010 just named his apical 10 AI stocks

CEO Daniel Dines sold 122,734 shares successful October 2025, followed by further income of 45,000 shares successful October and different 45,000 shares successful some December and January. Other executives sold alongside him. Markets interpreted the enactment arsenic a awesome of a deficiency of confidence.

The bull thesis rests connected UiPath’s improving profitability and positioning successful agentic automation. The institution delivered a beardown Q4, with gross of $481 cardinal increasing 14% year-over-year. Non-GAAP operating borderline expanded to astir 31%, portion ARR reached $1.853 billion, up 11% year-over-year, and dollar-based nett retention held astatine 107%. The institution besides achieved full-year GAAP profitability for the archetypal time. The numbers constituent to a concern that is inactive increasing portion showing existent operating leverage.

Read Entire Article